Philipp Gild

[Navid Roessler @n_roessler]

📊 PARPi show no clinically meaningful deterioration in health-related quality of life in mCRPC.

🔍 This meta-analysis underscores the critical need for nuanced interpretation of HRQoL data in the palliative setting.

👉🏼 https://t.co/TMBzFpOyrZ

[IMORU IX @IMORU]

Congrats to @mwvetterlein on a brilliant MANTA bulbar urethroplasty at IMORU XI! 3 days of top-notch live reconstructive surgeries here in Hamburg. Truly a world-class meeting. @UKEHamburg #Urology #LiveSurgery #Urethroplasty

[Jakob Klemm @JakobFelin]

Excited to share our latest work on female non-obstetric urogenital fistula repair! We dive into long-term patient-reported outcomes and provide a comprehensive review. Proud to collaborate with @mwvetterlein @DrShariat @UKEHamburg on this important work. R. Dahlem, M. Fisch.

[GURS @SocietyGURS]

Excellent plenary panel on the challenging to manage radiation induced posterior stenosis by @ajskokan @boyd_viersMD @MFrancescaMD @mwvetterlein. Challenging to manage patients requiring reconstructive experts! #AUA2024

[Malte W. Vetterlein @mwvetterlein]

Looking forward to a fantastic meeting with high-profile international faculty for live/semi-live surgery, meet-the-expert & poster sessions, state-of-the-art talks on the full spectrum of reconstructive urology. We’re excited to see you in Hamburg next year ⚓️⛴️👨‍⚕️👩‍⚕️Stay tuned.

[IMORU IX @IMORU]

Excited to announce a #SavetheDate for #IMORU25 in Hamburg, Germany @UKEHamburg. March 26-28, 2025. Navigating the Future of Reconstructive Urology. Stay tuned for further updates soon. https://t.co/CU2UNfeVsn

[Markus von Deimling @mvdeimling]

We need procedure-specific comorbidity assessments, as standard comorbidity indices are too generic to predict postop. morbidity! Check out our latest paper https://t.co/7znGGoDTsH
@mwvetterlein @DrShariat @MichaelRink_MD @JakobFelin @M_Koelker @VMS78880496 @FredKoenig @PAEGild

[Mara Koelker @M_Koelker]

Delighted to share our new publication on antithrombotic therapy among bladder cancer patients undergoing radical cystectomy

https://t.co/aegBkRj512

@ejsotweets @JakobFelin @mvdeimling @PAEGild, Roland Dahlem, Margit Fisch @MichaelRink_MD @mwvetterlein @UKEHamburg

[Malte W. Vetterlein @mwvetterlein]

Delighted to finally share our MANTA urethroplasty, a ventral approach for short obliterative segments in longer bulbar strictures https://t.co/ELJ8LHwiSq @BJUIjournal Phillip Marks @JakobFelin @FredKoenig @DingLiucheng, Florian Janisch @UKEHamburg

[Jakob Klemm @JakobFelin]

Thrilled to announce the publication of our in-depth Time-to-Complication Following Radical Cystectomy Analysis in @EurUrolFocus. https://t.co/Om486TEtxt
#urology #research @DrShariat @mvdeimling @M_Koelker @mwvetterlein @PAEGild

[Malte W. Vetterlein @mwvetterlein]

#EAU23 It‘s a wrap! 15 talks, 15 expert interviews, 2 board meetings, 1 guideline panel meeting, 1 chair @UKEHamburg #Urology Off to new endeavors! CU in #Paris #EAU24 @M_Koelker @FredKoenig @JakobFelin @DkFilipas @mvdeimling Florian Janisch @Uroweb @eau_yuo

[Tilo Freiwald @tilofrei]

Rethink the #complementsystem in nephrology and enjoy beautiful Hamburg! Join the Freiwald lab at the University Center Hamburg-Eppendorf @HCKH_Hamburg @UKEHamburg. BMBF-funded positions for PhD, Post-doc and Technician. Get in touch at https://t.co/NCAHRvV5PX.

[Elon Musk @elonmusk]

Should I step down as head of Twitter? I will abide by the results of this poll.

[Malte W. Vetterlein @mwvetterlein]

#VulvarCancer in a trans man - rare, easily overlooked, but devastating diagnosis. Have a look at our @BJUIjournal case of the month from @UKEHamburg @VMS78880496 @ArminSoave @MichaelRink_MD @EAU_YAURecon @Uroweb @EAUYAUrology
https://t.co/SsdbSsirVq

[Dejan K Filipas @DkFilipas]

Partial-nephrectomy should not be categorically withheld from patients with high complexity renal masses.

🚨Take a look at our new study fresh off the press🚨: https://t.co/32sG8ZpGT0

@xianmeyer
@MichaelRink_MD
@PAEGild
@mwvetterlein
@UrolOncol @Uroweb

[Malte W. Vetterlein @mwvetterlein]

Check out our recent validation of #PROMETRICS @atiqullah_aziz pentafecta criteria after open radical cystectomy: valuable tool, but needs refinement. Great work @mvdeimling @PAEGild @MichaelRink_MD @M_Koelker @JakobFelin @FredKoenig @UKEHamburg https://t.co/AtZwsHnRp3

[Philipp Gild @PAEGild]

@EndourologyNm @amy_krambeck @bsc_urology Very interesting, thanks for sharing. How do you clear the dust/sm fragments?Rinse out?

[Malte W. Vetterlein @mwvetterlein]

@PAEGild @JakobFelin @M_Koelker @MichaelRink_MD https://t.co/ZDJg3mIyu6

[Muhieddine Labban @mdlabban]

The 2022 #AQuilon team and alumni dinner at #AUA22 #NOLA

Our strength lies in our #Diversity and 🌍 representation

🇺🇸 🇬🇧 🇩🇪 🇻🇳 🇮🇹 🇷🇴 🇮🇳 🇨🇦 🇱🇧 🇸🇦 🇮🇶 🇨🇳 🇫🇷 🇧🇷 🇲🇽 🇹🇼 🇸🇬 🇵🇰 🇰🇷

[Michael Rink @MichaelRink_MD]

Spannende uro-onkologische Fortbildung am 6./7. August in HH. Präsenz und Virtuell möglich. Anmeldung über QR Code. @amerseburger @wulfingc @mwvetterlein @PAEGild @miokra